1. Contribution of Epithelial Plasticity to Therapy Resistance
   Patricia G. Santamaría et al, 2019, Journal of Clinical Medicine CrossRef
2. Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling
   Jiahui Wu et al, 2022, Frontiers in Oncology CrossRef
3. MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
   Chao-Ju Chen et al, 2021, Pharmaceuticals CrossRef
4. ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
   Zheng Liu et al, 2020, OncoImmunology CrossRef
5. Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
   Onat Kadioglu et al, 2018, Frontiers in Pharmacology CrossRef